Between 50 and 96% of drugs prescribed to neonatal and paediatric populations are used off-label, creating a clear need for clinical pharmacology studies and subsequent labelling. Key to the successful future of paediatric drug development is creating a collaborative community of professionals focusing on neonatal/paediatric clinical pharmacology. Offering the opportunity for students to participate in a pan-European project such as conect4children (c4c) may enhance their enthusiasm for the field of neonatal/paediatric clinical pharmacology. The primary objective of the concept is to evaluate the motivations and barriers medical students encounter when volunteering in neonatal/paediatric clinical pharmacology and to evaluate the role their tutors play.
To read full article, click here
